Phosphorylation of the p53 tumor suppressor protein is one of the key regulatory steps in its activation process. Serine 20 phosphorylation of p53 has been shown to be required for the activation of p53 following UV radiation, but the signaling pathway mediating UVinduced phosphorylation is unknown. Here, we determined the role of MAP kinases in UVB-induced phosphorylation and found that JNKs are directly involved in the phosphorylation of p53 at serine 20. In a mouse JB6 epidermal cell line, dominant negative JNK1 abrogated UVB-induced phosphorylation of p53 at serine 20, whereas dominant negative p38 kinase or its inhibitor, SB202190, partially attenuated the phosphorylation. In contrast, dominant negative ERK2 or the MEK1 inhibitor, PD98059, had no eect on p53 phosphorylation at serine 20. Importantly, UVB-activated or active recombinant JNK1/2, or the p38 kinase downstream target, MAPKAPK-2, but not ERKs or p38 kinase, phosphorylated p53 at serine 20 in vitro. Furthermore, phosphorylation of p53 at serine 20 by UVB-activated JNKs and UVB-induced p53-dependent transcriptional activity were suppressed in Jnk1 or Jnk2 knockout (Jnk1 7/7 or Jnk2
7/7

Introduction
The tumor suppressor protein p53 plays an essential role as a potent transcription factor in the maintenance of cellular genetic stability following DNA-damaging events. Normally, p53 exists in cells as a short-lived protein. In response to stress from DNA damaging agents including ultraviolet (UV) radiation, an accumulation of p53 protein occurs through post-translational mechanisms resulting in a subsequent increase in p53 activity, which then leads to either cell cycle arrest or apoptosis (Agarwal et al., 1998; Levine, 1997) . The increased level of p53 protein is primarily due to its decreased degradation (Fritsche et al., 1993; Kastan et al., 1991) . Degradation of p53 involves murine double minute 2 (MDM2), which binds to and targets p53 for ubiquitin-dependent proteolysis (Haupt et al., 1997; Kubbutat et al., 1997; Momand et al., 1992) . Recent studies indicated that the critical post-translational modi®cation required for p53 stabilization after DNA damage appears to be phosphorylation of p53 at serine 20. Serine 20 phosphorylation disrupts the interaction between p53 and MDM2 in vitro and substitution of serine 20 with alanine abolishes stabilization of p53 in response to UV radiation and g-radiation in vivo (Chehab et al., 1999; Unger et al., 1999a) . Cell cycle checkpoint kinase 2 (Chk2) was shown to stabilize and activate p53 through its phosphorylation of p53 at serine 20 in response to g-radiation (Chehab et al., 2000; Hirao et al., 2000) . However, cells with defective Chk2 still accumulate a normal amount of p53 protein following UV radiation (Hirao et al., 2000) . On the other hand, in cell lines derived from ataxia telangiectasia patients who have inactive ataxia telangiectasia mutated (ATM) protein that acts upstream of Chk2, p53 becomes phosphorylated at serine 20 after exposure to UV radiation (Chehab et al., 2000) . These results suggest that other cellular kinases must also phosphorylate p53 at serine 20 in vivo and are responsible for the stabilization and activation of p53 in response to UV radiation.
Activation of p53 by UV radiation correlates with induction of mitogen-activated protein (MAP) kinases, including c-Jun NH 2 -terminal kinases (JNKs), extracellular-signal-regulated protein kinases (ERKs), and p38 kinase (Bulavin et al., 1999; Huang et al., 1999a; She et al., 2000) . Recently, we showed that in response to UV radiation, ERKs and p38 kinase activate p53 by phosphorylation of serine 15, a speci®c site in the amino terminal domain (She et al., 2000) . Phosphorylation of serine 15 plays a vital role in the stabilization, up-regulation, and functional activation of p53 during cellular stress (Dumaz and Meek, 1999; Lambert et al., 1998 , She et al., 2000 Shieh et al., 1997; Unger et al., 1999b) . JNKs have also been shown to stabilize and activate p53 by phosphorylation through inhibition of MDM2 binding and targeting of p53 ubiquitination, but the phosphorylation site(s) required for JNKs stabilization and functional activation of p53 is(are) unclear (Fuchs et al., 1998b) . JNKs do not appear to mediate serine 15 phosphorylation of p53 after UV radiation (Fuchs et al., 1998b; She et al., 2000) . Therefore, these data pose the intriguing question of whether MAP kinases, especially JNKs, phosphorylate p53 at serine 20 and whether JNKs have a role in regulating UV-induced p53 activation. Here, using a phospho-speci®c antibody against p53 at serine 20 (Chehab et al., 1999 (Chehab et al., , 2000 , a dominant negative mutant of JNK1 and JNK1-and JNK2-de®cient (Jnk1 7/7 and Jnk2
7/7
) mouse embryonic ®broblasts (MEFs), we provide evidence that UVB-induced p53 phosphorylation at serine 20 (numbering according to Soussi et al., 1990 ) is directly mediated by JNKs both in vitro and in vivo. Our data demonstrate that activation of p53 induced by UVB radiation may depend on the activation of JNKs and subsequent phosphorylation of p53 at serine 20.
Results
Serine 20 phosphorylation is associated with p53 stabilization in response to UVB radiation Previous studies indicated that JB6 Cl 41 cells contain a wild-type p53 protein that activates p53-dependent transcription in response to UV exposure (Huang et al., 1997 (Huang et al., , 1999a She et al., 2000) . To determine whether p53 is phosphorylated at serine 20 in cells exposed to UV radiation in vivo, we used a speci®c antibody to detect p53 phosphorylation at serine 20 by Western blot analysis (Chehab et al., 1999 (Chehab et al., , 2000 . The phospho-speci®city of the antibody was con®rmed previously by using p53 peptides either not phosphorylated or phosphorylated at serine 15, threonine 18, or serine 20 (Chehab et al., 1999) or a full-length wildtype (WT) p53 or a p53 mutant with substitution of serine 20 with alanine (Chehab et al., 2000) . We found that in Cl 41 cells, UVB induced a time-dependent increase in p53 phosphorylation at serine 20 with maximal induction after 4 ± 6 h ( Figure 1a) . A doseresponse study indicated that 4 kJ/m 2 was the optimal dosage for induction of p53 phosphorylation at serine 20 (data not shown). These results are in agreement with previous ®ndings that UV radiation leads to increased phosphorylation of p53 at serine 20 (Chehab et al., 2000; Shieh et al., 1999) . Furthermore, immunoblotting of p53 protein revealed that increased levels of p53 protein correlated well with the observed increase in p53 phosphorylation at serine 20 following UVB radiation (Figure 1b) . MDM2 is transcriptionally induced by p53 and works as a feedback inhibitor by promoting p53 protein degradation and inhibiting p53 transcriptional activation (Haupt et al., 1997; Kubbutat et al., 1997; Oliner et al., 1993) . Here, we also found that MDM2 was induced by UVB radiation within 2 h and the level of MDM2 protein peaked at 4 ± 6 h ( Figure 1d ), adding further support to the theory that MDM2 is induced in response to p53. However, the amount of MDM2 binding to p53 remained at a constant but low level throughout the time course (Figure 1c ). These data are in agreement with previous ®ndings that serine 20 phosphorylation interferes with MDM2 binding (Chehab et al., 1999; Unger et al., 1999a) and suggest that UVB-induced serine 20 phosphorylation results in disassociation of MDM2 and stabilization of p53.
Suppression of JNKs blocks UVB-induced p53 phosphorylation at serine 20, whereas inactivated p38 kinase partially attenuates the phosphorylation MAP kinases, including JNKs, ERKs and p38 kinase, are strongly activated in cells exposed to UV radiation and their activities precede p53 phosphorylation and activation (She et al., 2000) , suggesting a possible role for MAP kinases acting upstream of p53 in a signal transduction pathway initiated by UV radiation. This possibility is supported by studies in which introduction of DN-JNK1 into Cl 41 cells, which speci®cally blocked UVB-induced phosphorylation of JNKs (Figure 2a) , but not phosphorylation of ERKs and p38 kinase (data not shown; Huang et al., 1999b; Zhang et al., 2001) , abrogated UVB-induced p53 phosphorylation at serine 20 (Figure 2b ). This result suggests that the intrinsic kinase activities of JNKs are required for UVB-induced serine 20 phosphorylation of p53. To determine whether ERKs and p38 kinase are also involved in the regulation of p53 phosphorylation at serine 20 in vivo, Cl 41 cells were stably transfected with DN-ERK2 or DN-p38 kinase as described in Materials and methods. Overexpression of DN-ERK2 or DN-p38 kinase speci®cally blocked UVB-induced phosphorylation of ERKs or p38 kinase, respectively (Figure 2a) . Overexpression of DN-ERK2 has been shown to have no eect on phosphorylation of JNKs and p38 kinase in DN-ERK2 transfectants; over- ) and cultured for the indicated times. Lysates were prepared from these cells. One-tenth of the Cl 41 lysate was used for immunodetection with MDM2 antibody (d), whereas the rest was used for immunoprecipitation with monoclonal antibodies against p53. The p53 immunoprecipitates were resolved by SDS ± PAGE and transferred to PVDF membrane. The membrane was ®rst immunoblotted with a phospho-speci®c antibody against p53 at serine 20 (a), stripped, and then reprobed with an antibody against total p53 (b) or MDM2 (c). IP, immunoprecipitate. The data shown are representative of three independent experiments with similar results expression of DN-p38 kinase had no eect on phosphorylation of ERKs and JNKs in DN-p38 kinase transfectants (data not shown; Zhang et al., 2001) . The expression of DN-p38 kinase, but not DN-ERK2, signi®cantly inhibited UVB-induced p53 phosphorylation at serine 20 ( Figure 2b ). Furthermore, pretreatment with 0.5 ± 2 mM SB202190, a speci®c inhibitor of p38 kinase (Hazzalin et al., 1996) , which markedly inhibited UVB-induced phosphorylation of p38 kinase (Figure 3a) , also partially impaired UVB-induced p53 phosphorylation at serine 20 ( Figure 3a ). In contrast, pretreatment with 12.5 ± 50 mM PD98059, a speci®c inhibitor of MEK1 (Alessi et al., 1995) , which blocked UVB-induced phosphorylation of ERKs (Figure 3a) , had no eect ( Figure 3b ). These observations show that UVB-responsive JNKs are major components of a previously unrecognized signaling pathway leading to p53 phosphorylation at serine 20. On the other hand, the levels of p53 protein were shown to be partially inhibited by expression of DN-JNK1, DN-ERK2 and DN-p38 kinase or pretreatment with PD98059 and SB202190, although the UVB-induced serine 20 phosphorylation was blocked by DN-JNK1 or not inhibited by inactivated ERKs (Figures 2b and 3b ). Our previous study showed that serine 15 phosphorylation of p53 by UVB-activated ERKs and p38 kinase was also involved in the stabilization of p53 (She et al., 2000) . These results suggested that UVB-induced serine 20 phosphorylation may act synergistically with serine 15 phosphorylation to stabilize p53.
JNKs and MAPKAPK-2 phosphorylate p53 at serine 20
p53 is known to associate with JNKs (Adler et al., 1997; Fuchs et al., 1998a) , ERKs, and p38 kinases (Huang et al., 1999a; She et al., 2000) . Therefore, we tested whether p53 is a substrate for JNKs, ERKs, or p38 kinase by performing immune complex kinase assays of UVB-activated JNKs, ERKs, and p38 kinase using a full-length GST-p53 fusion protein as the exogenous substrate. This experiment revealed that the exogenous p53 protein was phosphorylated at serine 20 by UVB-activated JNKs, but not by activated ERKs or p38 kinase ( Figure 4a ). Intriguingly, endogenous p53 was found to be co-precipitated in the antiphospho-JNKs immunoprecipitates and could be ) and cultured for 30 min. Lysates were prepared from these cells and phosphorylated or total proteins of JNKs, ERKs, or p38 kinase were immunodetected with phospho-speci®c or total JNKs, ERKs, or p38 kinase antibodies. (b) Serum-starved Cl 41 cell stable transfectants as indicated were untreated or exposed to UVB (4 kJ/m 2 ) and cultured for 4 h. Lysates were prepared from these cells and the levels of phosphorylated of p53 at serine 20 and total p53 were measured as described in Figure 1 . The data shown are representative of three independent experiments with similar results Figure 3 Inhibitor of p38 kinase, but not MEK1, partially impairs UVB-induced p53 phosphorylation at serine 20. Serumstarved Cl 41 cells were pretreated with MEK1 inhibitor, PD98059, or p38 kinase inhibitor, SB202190, for 30 min at the concentration indicated, followed by exposure of the cells to UVB (4 kJ/m 2 ) radiation and then cultured for 30 min (a) and 4 h (b). Lysates were prepared from these cells and the phosphorylated and total proteins of ERKs and p38 kinase (a), as well as the levels of phosphorylated p53 at serine 20 and total p53 (b), were measured as described in Figure 2 . The data shown are representative of two independent experiments with similar results Figure 4 p53 is phosphorylated at serine 20 in vitro by UVB-activated or active JNKs and MAPKAPK-2. Serum-starved Cl 41 cells were untreated or exposed to UVB (4 kJ/m 2 ) and cultured for 30 min. Lysates (500 mg of protein) were prepared from these cells and the immunoprecipitated phosphorylated JNKs, ERKs, or p38 kinase (a) or the immunoprecipitated MSK1 or MAPKAPK-2 (c) were assayed for kinase activity by adding puri®ed GST-p53 as exogenous substrate. Serine 20 phosphorylation and total levels of exogenous and endogenous p53 were measured as described in Figure 1 . IB, immunoblotting. KDa, M r in thousands. Phosphorylation of p53 at serine 20 or serine 15, or the phosphorylation of c-Jun at serine 63, Elk-1 at serine 383, and ATF-2 at threonine 71 by active recombinant kinases was carried out at 308C for 1 h in the presence of speci®c substrate, kinase buer, 200 mM ATP, and one of the MAP kinase family (b) or one of their downstream kinases (d). The phosphorylated proteins were immunodetected using phospho-speci®c antibodies. The data shown are representative of two (c and d) or three (a and b) independent experiments with similar results phosphorylated at serine 20 at a level substantially above that observed in vivo at 1 h after UVB radiation (Figure 1 ). To con®rm that p53 was phosphorylated at serine 20 by JNKs, rather than a contaminating protein kinase, we incubated the p53 fusion protein with one of several pure and active recombinant MAP kinase family members in the presence of ATP. The results veri®ed that active JNK1/2, but not active ERK1/2 or p38 kinase, could directly phosphorylate p53 protein at serine 20 (Figure 4b ). Active ERK1/2 and p38 kinase, however, did exert their activity to phosphorylate Elk-1 and ATF-2, respectively (Figure 4b ). Reprobing the same membrane with an antibody to phosphorylated serine 15 (Hirao et al., 2000) , we found that active ERKs or p38 kinase, but not active JNKs, phosphorylated p53 at serine 15 (Figure 4b ) as shown previously (She et al., 2000) . In addition to the phosphorylation of p53 at serine 20, active JNK1/2 also exert their activity to phosphorylate c-Jun (Figure 4b ). This demonstrated the site speci®city of p53 phosphorylation by JNKs, ERKs and p38 kinase. Although p38 kinase could not directly phosphorylate p53 at serine 20, inactivated p38 kinase signi®cantly inhibited serine 20 phosphorylation in vivo (Figures 2b and 3b ). This led us to test whether a downstream member of p38 kinase, such as MSK1 or MAPKAPK-2, catalyzes the phosphorylation of p53 at serine 20. In JB6 Cl 41 cells, UVB radiation also activated MSK1 and MAPKAPK-2, whereas inhibition of p38 kinase blocked UVB-induced activation of MSK1 or MAPKAPK-2 (Nomura et al., 2001) . We performed in vitro kinase assays and found that UVBactivated or active recombinant MAPKAPK-2 could phosphorylate exogenous or endogenous p53 at serine 20, but activated MSK1 or the ERKs downstream kinase, RSK-2, did not phosphorylate p53 at serine 20 (Figure 4b,c) . These results, taken together with the other data from this study, strongly demonstrate that JNKs and MAPKAPK-2 are direct mediators of UVBinduced p53 phosphorylation at serine 20.
Serine 20 phosphorylation of p53 by UVB-activated JNKs is repressed in Jnk1 7/7 and Jnk2 7/7 MEFs
To further determine whether phosphorylation of p53 at serine 20 requires JNKs, we prepared WT, JNK1-and JNK2-de®cient MEFs that were derived from mice harboring a targeted disruption of each of their respective genes Yang et al., 1998) . The genotype of Jnk1 7/7 or Jnk2 7/7 MEFs was con®rmed by PCR (data not shown). Protein immunoblotting analysis revealed a complete loss of JNK1 or JNK2 protein in Jnk1 7/7 or Jnk2 7/7 MEFs, respectively; whereas disruption of the Jnk1 and Jnk2 gene did not alter expression of ERKs or p38 kinase (Figure 5a) . JNKs have been shown to phosphorylate c-Jun at serine residues 63 and 73 (Derijard et al., 1994) . Analysis of JNK activity by using c-Jun as a substrate showed a marked decrease of activity in Jnk1 7/7 or Jnk2 7/7 MEFs exposed to UVB radiation (Figure 5b ). These data indicate that the knockout of the Jnk1 or Jnk2 gene was eective and speci®c. Using the Jnk1 7/7 and Jnk2 7/7 MEFs, we further performed immune complex kinase assays of UVB-activated JNKs with p53 fusion protein as the substrate. We found that phosphorylation of p53 at serine 20 by UVB-activated JNKs was inhibited in Jnk1 7/7 and Jnk2 7/7 MEFs (Figure 5b ). These results con®rm that JNKs are required for serine 20 phosphorylation of p53 in response to UV radiation.
Serine 20 phosphorylation of p53 mediated by JNKs is associated with p53-dependent transcriptional activation and apoptosis
To assess the functional role of JNKs in mediating the phosphorylation of p53 at serine 20 in response to UV radiation, we transfected WT, Jnk1 7/7 or Jnk2
MEFs with a PG13-luciferase reporter gene, which is a typical p53-binding-site reporter construct (el-Deiry et al., 1992) . Disruption of the Jnk1 or Jnk2 gene caused a marked decrease in UVB-induced p53-dependent transcriptional activation (Figure 6a ), indicating that JNKs are functionally required for p53-dependent transcription. Because induction of apoptosis in 7/7 and Jnk2 7/7 MEFs were untreated or exposed to UVB (4 kJ/m 2 ) and then cultured for 30 min. Lysates (500 mg of protein) were prepared from these cells and the immunoprecipitated phosphorylated JNKs were assayed for kinase activity by adding puri®ed c-Jun or p53 fusion protein as substrate. Phosphorylation was immunodetected with antibodies to phospho-c-Jun at serine 63 or serine 73, or phospho-p53 at serine 20. The level of p53 protein was immunodetected with a p53 antibody. The data shown are representative of two independent experiments with similar results response to DNA damage and cellular stress is one of the main biologic functions of p53 (Lowe et al., 1993; Merritt et al., 1994) , we examined whether UV-induced serine 20 phosphorylation of p53 by JNKs alters this response. Analysis of DNA fragmentation revealed that the p53 7/7 MEFs were defective in the apoptotic response to UVB radiation (Figure 6b ), indicating that UVB-induced apoptosis is p53-dependent. Furthermore, mutation of serine 20 to alanine repressed UVB-induced p53-mediated apoptosis (Figure 6c ). In addition, the Jnk1 7/7 and Jnk2 7/7 MEFs were also resistant to apoptosis induced by UVB radiation (Figure 6d ). These data indicate that JNK1 or JNK2 de®ciency causes a defect in the apoptotic response of MEFs to UVB radiation and suggest that JNKs are required for UVB-induced apoptosis, which is mediated, at least in part, by p53 phosphorylation at serine 20.
Discussion
Activation of p53 in response to DNA damage involves an increase in the level of p53 protein that results from its stabilization (Fritsche et al., 1993; Kastan et al., 1991) . The stabilization of p53 is due to inhibition of MDM2-dependent p53 degradation. MDM2, through complex formation with the N terminus of p53 (amino acids 19 ± 26), both represses p53 transcriptional activation (Oliner et al., 1993) and mediates the degradation of p53 through the ubiquitin pathway (Haupt et al., 1997; Kubbutat et al., 1997) . The serine 20 residue lies directly on the MDM2-binding domain of p53. Biochemical and genetic data indicate the phosphorylation of serine 20 interferes with MDM2 binding and subsequently stabilizes and activates p53 in response to DNA damage (Chehab et al., 1999; Unger et al., 1999a) . Mutations at either serine 15 or serine 20, but not other sites, impair the apoptotic activity of p53 (Unger et al., 1999a,b) , suggesting that along with serine 15, phosphorylation of serine 20 plays a pivotal role in regulating the functional activity of p53. Therefore, identifying the kinase(s) that phosphorylates serine 20 will help to delineate the signaling cascade leading to functional activation of p53. UV radiation was previously shown to induce p53 phosphorylation at serine 20 (Chehab et al., 2000; Shieh et al., 1999) . The critical kinase mediating this UV-responsive phosphorylation is, however, not documented. One of the major UV responsive pathways is the ras/MAP kinase cascade, including JNKs, ERKs, and p38 kinase signaling components (Adler et al., 1995 (Adler et al., , 1996 Dhanasekaran and Premkumar, 1998) . JNKs have been shown to phosphorylate p53 at serine 34 in vitro (Hu et al., 1997; Milne et al., 1995) . Very recently, we reported that ERKs and p38 kinase mediate UV-induced p53 phosphorylation at serine 15 (She et al., 2000) and serine 389 is also a target for phosphorylation by p38 kinase following UV radiation (Huang et al., 1999a) . However, the p53 phosphorylation sites mediated by MAP kinases are not completely identi®ed. In the present study, we further determined the role of MAP kinases in UVB-induced p53 phosphorylation at serine 20. Exposure of Cl 41 cells to UVB radiation led to serine 20 phosphorylation of p53 and its accumulation and reduced MDM2 binding to p53. Overexpression of a dominant negative mutant of JNK1 blocked the phosphorylation of p53 at serine 7/7 and Jnk2 7/7 MEFs were transfected with a PG13-Luc reporter plasmid and assayed for p53-dependent transcriptional activity 48 h later. MEFs were untreated and used as controls or exposed to UVB (4 kJ/m 2 ) and cultured for 6 or 12 h. Luciferase activity in WT, Jnk1 7/7 and Jnk2 7/7 MEFs was expressed as relative p53 activity compared with respective controls (She et al., 2000) . Data from three independent experiments were averaged and are presented as mean+s.e. *P50.01, WT vs Jnk1 7/7 or Jnk2 7/7 MEFs. (b) UVB-induced p53-mediated apoptosis. p53 +/+ or p53 7/7 MEFs were exposed to UVB (4 kJ/m 20, whereas overexpression of a dominant negative p38 kinase or pretreatment of cells with a p38 kinase inhibitor, SB202190, partially impaired the phosphorylation. In contrast, inactivated ERKs had no eect on the phosphorylation. Most importantly, UVB-activated or active recombinant JNK1/2 or the p38 kinase downstream target, MAPKAPK-2, was shown to phosphorylate the p53 protein at serine 20 in vitro. Furthermore, following UVB radiation, mouse embryonic ®broblasts with targeted disruption of the Jnk1 or Jnk2 gene suppressed the phosphorylation of p53 at serine 20 by JNKs and p53-dependent transcriptional activation, but protected ®broblasts against UVBinduced p53-mediated apoptosis. In addition, substitution of serine 20 by alanine impaired UVB-induced apoptotic activity of p53. All these data clearly demonstrate that JNKs play a major and critical role in UVB-induced phosphorylation of p53 at serine 20, suggesting that induction of p53 transcriptional activation and apoptosis by UVB may depend mainly on the activities of JNKs and their phosphorylation of p53 at serine 20.
JNKs have been shown to associate with p53 requiring amino acids 97 ± 155 within the p53 central domain (Adler et al., 1997; Fuchs et al., 1998a) . In nonstressed cells, JNKs bind to and degrade p53 in an MDM2-independent fashion (Fuchs et al., 1998a) . Following activation by UV radiation or a constitutively active form of MEKK1 that acts upstream of JNKs, the extent of JNKs association with p53 decreases immensely (Fuchs et al., 1998a) , and JNKs inversely phosphorylate and stabilize p53 by abrogating the MDM2 association, increasing p53 transactivation, and potentiating the ability of p53 to elicit cellular apoptosis (Fuchs et al., 1998b) . However, the phosphorylation site(s) required for JNKs stabilization and functional activation of p53 is not identi®ed (Fuchs et al., 1998b) . Phosphorylation of serine 15, a key target during p53 activation, is critical for the stabilization (She et al., 2000; Shieh et al., 1997), upregulation (Dumaz and Meek, 1999; Lambert et al., 1998; She et al., 2000) , and functional activation (Unger et al., 1999b) of p53. We previously determined whether serine 15 in p53 is a phosphorylation site for JNKs, but JNKs does not appear to mediate serine 15 phosphorylation of p53 after UVB radiation (Fuchs et al., 1998b; She et al., 2000) . Combined with this study, we con®rmed that ERKs and p38 kinase phosphorylate p53 at serine 15 and found that serine 20 is a target phosphorylation site for JNKs in response to UVB radiation.
Many dierences exist in the sites and kinetics of p53 phosphorylation after UV radiation compared with gradiation (Kapoor and Lozano, 1998; Lu et al., 1998; Prives and Hall, 1999; Shieh et al., 1999) . In response to g-radiation, phosphorylation of p53 at serine 20 and activation of p53 depend on the ATM/Chk2 signaling pathway (Chehab et al., 2000; Hirao et al., 2000) . Cells lacking ATM or Chk2, however, do not exhibit aberrant p53 stabilization or defects in serine 20 phosphorylation following UV radiation (Chehab et al., 2000; Hirao et al., 2000; Siliciano et al., 1997) . Indeed, the kinase activity of ATM is not increased in UV-radiated cells (Canman et al., 1998) , whereas gradiation is a poor activator of JNKs in many cell systems (Maki and Howley, 1997) . Thus, these two DNA damaging events use dierent signaling pathways for serine 20 phosphorylation and activation of p53.
Overall, our data suggest that JNKs mediate phosphorylation of p53 at serine 20 resulting in the regulation of p53 activity in response to UV radiation. Together with our recent ®ndings that (1) UV-activated ERKs and p38 kinase phosphorylate p53 at serine 15, leading to its stabilization and activation (She et al., 2000) ; and (2) UV-activated p38 kinase phosphorylates p53 at serine 389 to stimulate its DNA-binding ability (Huang et al., 1999a) , we propose a model as follows. Upon exposure to UV radiation, JNKs and MAP-KAPK-2 phosphorylate p53 at serine 20 and ERKs and p38 kinase simultaneously mediate serine 15 phosphorylation. Serine 20 phosphorylation may act synergistically with serine 15 phosphorylation to stabilize p53 by reducing its binding to MDM2. On the other hand, p53 is phosphorylated at serine 389 by p38 kinase to enhance its DNA-binding ability. The newly phosphorylated p53 protein accumulates and becomes activated to elicit its biological eects. Our data are in agreement with the recent proposal that to achieve optimal activity of p53, multiple sites may need to be phosphorylated by a p53-associated complex containing several kinases (Shieh et al., 1999) . In addition to the role of ERKs and p38 kinase in phosphorylation of p53, our results identify JNKs, for the ®rst time, as major direct signal mediators of p53 phosphorylation at serine 20 following UV radiation. In addition, we show that JNKs are functionally required for UV-induced p53-dependent transcription and apoptosis.
Materials and methods
Plasmids and reagents
CMV-neo vector plasmid and p53 luciferase reporter plasmid (PG13-Luc) were constructed as reported previously (Huang et al., 1996a (Huang et al., , 1997 . Dominant negative (DN) mutants of JNK1, ERK2, and p38 kinase were generous gifts from Dr Roger J Davis (Chen et al., 1996; Derijard et al., 1994) , Dr Melanie H Cobb (Frost et al., 1994) , and Dr Mercedes Rincon (Raingeaud et al., 1995; Rincon et al., 1998) , respectively; wild-type human p53 (wt p53) and a p53 mutant with substitution of serine 20 to alanine (p53 S20A) were generous gifts from Dr Thanos D Halazonetis (Chehab et al., 1999 (Chehab et al., , 2000 ; active recombinant JNK1 (85 units/mg), JNK2 (100 units/mg), ERK1 (100 units/mg), p38 kinase (157 units/ mg), mitogen activated protein kinase-activated protein kinase 2 (MAPKAPK-2) (442 units/mg), mitogen-and stress-activated protein kinase 1 (MSK1) (167 units/mg), p90 ribosomal S6 kinase 2 (RSK2) (350 units/mg), and polyclonal sheep IgG against MSK1 antibody were from Upstate Biotechnology, Inc. (Lake Placid, NY, USA); and active recombinant ERK2 (10 000 units/mg) and c-Jun fusion proteins, phospho-speci®c p53 (Ser15) and p53 (Ser20) antibodies, phospho-speci®c c-Jun (Ser63), c-Jun (Ser73), Elk-1 (Ser383) and ATF-2 (Thr711) antibodies, phosphoPlus JNK, p44/42 MAP kinase, and p38 kinase antibody kits, JNK, p44/42 MAP kinase, and p38 kinase assay kits were purchased from New England BioLabs Inc. (Beverly, MA, USA). The purity of all of the active recombinant kinases is greater than 90%, except for ERK1 and RSK2, which are greater than 50%. The monoclonal mouse IgG against JNK1/JNK2 antibody was from Pharmingen (Los Angeles, CA, USA); monoclonal mouse IgG against p53 antibody (Ab-1) was from Oncogene Research Products (Pasadena, CA, USA); p53 fusion protein, polyclonal rabbit IgG against p53 and MDM2 antibodies, and polyclonal goat IgG against MAPKAPK-2 antibody were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); MEK1-speci®c inhibitor, PD98059, was from Biomol Research Laboratories, Inc. (Plymouth Meeting, PA, USA); p38 kinase inhibitor, SB202190, was from Calbiochem (LaJolla, CA, USA); LipofectAMINE and LipofectAMINE PLUS reagents, Eagle's minimum essential medium (MEM), and Dulbecco's modi®ed eagle medium (DMEM) were from Life Technologies, Inc. (Baltimore, MD, USA); fetal bovine serum (FBS) was from Biowhittaker, Inc. (Baltimore, MD, USA); and luciferase substrate was from Promega (Madison, WI, USA).
Cell culture
JB6 mouse epidermal cell line Cl 41 and its stable transfectants, Cl 41 CMV-neo, Cl 41 DN-JNK1 mass1, Cl 41 DN-ERK2 B3 mass1, and Cl 41 DN-p38 G7 were cultured in monolayers at 378C and 5% CO 2 using Eagle's MEM containing 5% FBS, 2 mM L-glutamine, and 25 mg/ml gentamicin (Huang et al., 1996b (Huang et al., , 1999a . Wild-type (WT), Jnk1 7/7 and Jnk2 7/7 primary MEFs were generated from embryonic day 14 mouse embryos and cultured for a maximum of 10 passages in DMEM medium with 10% FBS, 2 mM L-glutamine and antibiotics Loo and Cotman, 1994; Yang et al., 1998) . p53 +/+ and p53
7/7
MEFs were cultured in DMEM medium with 10% FBS, 2 mM L-glutamine, and 25 mg/ml gentamicin (Livingstone et al., 1992) .
Generation of stable cotransfectants
JB6 Cl 41 cells were transfected with CMV-neo vector with or without the cDNA of dominant negative mutants of JNK1, ERK2, or p38 kinase by using LipofectAMINE following the manufacturer's instructions. The stable transfectants were obtained by selection for G418 resistance (300 mg/ml) and further con®rmed by assay of respective activity as described (Huang et al., 1999a,b; Watts et al., 1998) .
Immunoblotting and immunoprecipitation
Immunoblotting for phosphorylated proteins of JNKs, ERKs, and p38 kinase was carried out using phosphospeci®c MAP kinase antibodies against phosphorylated sites of JNKs, ERKs, or p38 kinase, respectively (She et al., 2000) .
To study the eect of UVB radiation on the induction of p53 at serine 20 and the interaction of p53 with MDM2 in vivo, p53 protein was ®rst immunoprecipitated with a speci®c antibody against p53. The immunocomplex was then analysed by SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblotted with the appropriate antibodies. Brie¯y, JB6 Cl 41 cells or transfectants were cultured in 100-mm dishes with 5% FBS MEM until they reached 80 ± 90%
con¯uence. Then, the cells were starved by culturing them in 0.1% FBS MEM for 24 h. The cells were exposed to UVB radiation to induce p53 phosphorylation at serine 20 and then were disrupted on ice for 30 min in lysis buer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM b-glycerolphosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin, and 1 mM phenylmethylsulphonyl¯uoride) and centrifuged at 14 000 r.p.m. for 10 min in a microcentrifuge. The lysates containing 500 mg of protein were immunoprecipitated using monoclonal mouse IgG antibody against p53 and then protein A/G plus agarose. The beads were washed extensively to eliminate nonspeci®c binding and levels of phosphorylated proteins of p53 at serine 20, total p53, and MDM2 were selectively measured by Western immunoblotting using a speci®c antibody and a chemi¯uorescence detection system (ECF; Amersham Pharmacia Biotech).
In vitro kinase assay
Assays of JNKs, ERKs, p38 kinase, MAPKAPK-2, and MSK1 were carried out as described in the protocol of New England BioLabs. In brief, JB6 Cl 41 cells, WT, Jnk1 7/7 or Jnk2 7/7 MEFs were starved for 24 h in 0.1% FBS MEM or DMEM at 378C in a 5% CO 2 atmosphere incubator. The cells were exposed to UVB (4 kJ/m 2 ) and cultured for an additional 30 min. Then, the cells were washed once with icecold phosphate-buered saline and disrupted in 300 ml of the lysis buer. The lysates were sonicated and centrifuged. Endogenous JNKs, ERKs, p38 kinase, MAPKAPK-2, or MSK1 were immunoprecipitated from the supernatant fraction, which contained 500 mg of protein, by incubating with the antibody against speci®c phospho-JNKs, ERKs, or p38 kinase, or an antibody against MAPKAPK-2 or MSK1 for 6 ± 10 h at 48C, followed by incubation with protein A/G plus-agarose for another 4 h. The beads were washed twice with 500 ml of the lysis buer and twice with 500 ml of kinase buer (25 mM Tris, pH 7.5, 5 mM b-glycerolphosphate, 2 mM dithiothreitol, 0.1 mM Na 3 VO 4 , and 10 mM MgCl 2 ). The kinase reactions were carried out in the presence of 200 mM ATP at 308C for 30 min or 1 h using 2 mg of c-Jun as substrate for JNKs or 3 mg of p53 as substrate for all of the kinases as above. The phosphorylated proteins were detected by immunoblotting using phospho-speci®c antibodies.
Protein phosphorylation assay in vitro
Phosphorylation of p53, c-Jun, Elk-1 or ATF-2 by active recombinant JNK1, JNK2, ERK1, ERK2, p38 kinase, MAPKAPK-2, MSK1, or RSK2 was carried out at 308C for 1 h in the presence of the kinase buer with 200 mM ATP and 3 mg of p53, 2 mg of c-Jun, Elk-1 or ATF-2 as substrate. The phosphorylated p53 protein was detected by immunoblotting using a phospho-speci®c antibody.
Assay for p53-dependent transcription activity WT, Jnk1 7/7 and Jnk2 7/7 MEFs were cultured in 6-well plates until cell density reached 80 ± 90% con¯uence. Two micrograms of p53 luciferase reporter plasmid (PG13-Luc) were used to transfect each well by using LipofectAMINE PLUS following the manufacturer's instructions. Forty-eight hours post-transfection, the MEFs were subjected to the assay for p53-dependent transcriptional activity as described (She et al., 2000) . Brie¯y, 1610 4 viable WT, Jnk1 7/7 or Jnk2 7/7 MEFs transfected with PG13-Luc were suspended in 100 ml of 10% FBS DMEM and then seeded into each well of a 96-well plate. Plates were incubated at 378C in a humidi®ed atmosphere of 5% CO 2 until the MEFs reached 80 ± 90% con¯uence. The MEFs were starved by culturing them in 0.1% FBS DMEM for 12 h. Then, the MEFs were untreated and used as controls or exposed to UVB (4 kJ/m 2 ) to induce p53 activity and cultured for the indicated times. The MEFs were extracted with lysis buer (100 mM K 2 HPO 4 , pH 7.8, 1% Triton X-100, 1 mM dithiothreitol, and 2 mM EDTA) and luciferase activity was measured using a luminometer (Monolight 20/0). The results were expressed as relative p53 activity compared to controls (She et al., 2000) .
DNA fragmentation assay
WT, Jnk1 7/7 , Jnk2 7/7 or p53 7/7 MEFs were grown in 100-mm dishes and when cell density reached 80 ± 90% con¯uence the MEFs were untreated or exposed to UVB (4 kJ/m 2 ) and cultured for 20 h. Both detached and attached MEFs were harvested by scraping and centrifugation. The MEFs were then disrupted with lysis buer (5 mM Tris, pH 8.0, 20 mM EDTA and 0.5% Triton X-100) on ice for 45 min. After centrifugation at 14 000 r.p.m. for 45 min at 48C, the supernatant fraction that contained fragmented DNA was saved, while genomic DNA was excluded in the pellet. The fragmented DNA was extracted from the supernatant fraction, which contained 1 mg of protein, twice with phenol : chloroform : isoamyl alcohol (25 : 24 : 1 v/v) and once with chloroform, and then precipitated overnight at 7208C with ethanol and 5 M NaCl. The DNA pellet was washed once with 70% ethanol and resuspended in Tris-EDTA buer (pH 8.0) with 100 mg/ml RNase and incubated at 378C for 2 h. The DNA fragments were separated by 1.8% agarose gel electrophoresis and visualized under UV light (Chen et al., 1999) . To determine whether mutation of serine 20 to alanine impairs the apoptotic activity of p53 following UVB radiation, p53 7/7 MEFs were cultured in 100-mm dishes until cell density reached 80 ± 90% con¯uence. Ten mg of expression plasmid DNA of either wt p53 or mutant p53 S20A were used to transfect cells in each dish by using LipofectAMINE PLUS reagent following the manufacturer's instructions. Seventy-two hours post-transfection, the transfectants were subjected to the DNA fragmentation assay as described above.
